Asahi Life Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444K | Buy |
845
+160
| +23% | +$84K | 0.26% | 88 |
|
|
2025
Q1 | $434K | Buy |
+685
| New | +$434K | 0.28% | 74 |
|
|
2024
Q2 | – | Sell |
-227
| Closed | -$218K | – | 204 |
|
|
2024
Q1 | $218K | Buy |
+227
| New | +$218K | 0.13% | 164 |
|
|
2023
Q3 | – | Sell |
-560
| Closed | -$402K | – | 230 |
|
|
2023
Q2 | $402K | Sell |
560
-80
| -13% | -$57.5K | 0.13% | 82 |
|
|
2023
Q1 | $526K | Buy |
+640
| New | +$526K | 0.17% | 67 |
|
|
2022
Q3 | – | Sell |
-200
| Closed | -$118K | – | 294 |
|
|
2022
Q2 | $118K | Sell |
200
-630
| -76% | -$372K | 0.03% | 231 |
|
|
2022
Q1 | $580K | Buy |
+830
| New | +$580K | 0.08% | 69 |
|
|
2021
Q3 | – | Sell |
-1,060
| Closed | -$592K | – | 289 |
|
|
2021
Q2 | $592K | Buy |
1,060
+155
| +17% | +$86.6K | 0.08% | 62 |
|
|
2021
Q1 | $428K | Sell |
905
-150
| -14% | -$70.9K | 0.06% | 128 |
|
|
2020
Q4 | $510K | Buy |
+1,055
| New | +$510K | 0.07% | 105 |
|
|
2019
Q4 | – | Sell |
-1,350
| Closed | -$374K | – | 256 |
|
|
2019
Q3 | $374K | Buy |
+1,350
| New | +$374K | 0.06% | 110 |
|